Status:
COMPLETED
Inhaled A1AT in Adult Stable Bronchiectasis
Lead Sponsor:
Hospital Universitari Vall d'Hebron Research Institute
Collaborating Sponsors:
Bayer
Sociedad Española de Neumología y Cirugía Torácica
Conditions:
Bronchiectasis Adult
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Aim: to investigate the influence of alpha1-antitrypsin (A1-AT) nebulization on levels of A1-AT in BAL and plasma in patients with stable bronchiectasis. Method: single-blind placebo-controlled rando...
Detailed Description
Effects of inhaled alpha-1-anti-trypsin in bronchiectasis patients with chronic bronchial infection. Introduction: one of the main features of bronchiectasis is chronic and deregulated neutrophilic b...
Eligibility Criteria
Inclusion
- Stable clinical conditions (no use of systemic antibiotic or steroid treatment in the last month)
- diagnosis of bronchiectasis bt CT scan
- chronic purulent or mucopurulent expectoration (daily sputum expectoration in the last 6 months or more)
Exclusion
- Cystic fibrosis
- interstitial lung disease as cause of bronchiectasis
Key Trial Info
Start Date :
June 1 1996
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 7 1999
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03383939
Start Date
June 1 1996
End Date
September 7 1999
Last Update
December 27 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.